Gout drug Colchicine to be tested as COVID-19 treatment in UK trial, Reuters

The RECOVERY trial, which is world ' s largest clinical trial of treatments for patients hospitalised with COVID-19, will randomly allocate at least 2,500 patients recruited to receive the anti-inflammatory colchicine, as inflammation is considered to play a major role in COVID-19.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news